Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-020-00890-2
Published Online: 2020-07-29
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jinnouchi, Hideaki
Imori, Makoto
Nishiyama, Hiroshi
Imaoka, Takeshi
Funding for this research was provided by:
Eli Lilly and Company
Eli Lilly Japan K.K
Text and Data Mining valid from 2020-07-29
Version of Record valid from 2020-07-29
Article History
Received: 27 March 2020
First Online: 29 July 2020